FcgammaRII Polymorphism: Key Marker for Acute Coronary Syndrome
The present invention discloses a significant altered distribution of FcgammaRIIa genotypes in the presence of CAD as compared to healthy controls. A detailed analysis of the FcgammaRIIa polymorphism revealed a significantly altered distribution within the group of patients with ACS as compared to the group with stable angina pectoris (SAP).
Further Information: PDF
Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V.
Phone: +49 (0)89/1205-6000
Contact
Dr. Wolfgang Knappe
